You are here

N Sup Omega Nitro-L-Arjinin Metil Ester Ile Indüklenen Hipertansiyonlu Siçanlarin Renal Doku Ksantin Oksidaz Ve Adenozin Deaminaz Aktiviteleri

Xanthine Oxidase and Adenosine Deaminase Activities of Renal Tissue in Rats with Hypertension Induced by N Sup Omega Nitro-L-Arginine Methyl Ester

Journal Name:

Publication Year:

Abstract (2. Language): 
Hypertension may alter kidney functions negatively. Purine metabolism may be affected from constricted blood vessels and increased cardiac output, because of hypertension. Nitric oxide synthase (NOS) inhibition by N sup omega Nitro-L- Arginine Methyl Ester (L-NAME) produces hypertension in rats. The aim of this study was to investigate adenosine deaminase (AD) and xanthine oxidase (XO) activities of renal tissue in rats after NOS inhibition. Rats were divided into three groups; one of them was control group and the others were study groups treated with 100 or 500 mg per liter L-NAME in drinking tap water for 15 days. After above-mentioned treatment, arterial blood pressure was measured via carotid artery cannula on anaesthetised rats. Activities of AD and XO were carried out in the renal tissue. Systolic blood pressures showed significant increase in both L-NAME groups. XO activities of L-NAME groups were increased significantly compared to control group. increased AD activities were also observed in L-NAME groups but this increase did not reach statistical significance. There was no significant difference in XO and AD activities between 100 mg and 500 mg L-NAME groups. in conclusion, we speculated that hypertension induced by L-NAME causes increased purine nucleotides. Then, accumulated purine nucleotides may be removed from the renal tissue by increased XO and AD enzyme activities.
Abstract (Original Language): 
Hipertansiyon böbrek fonksiyonlarini negatif yönde degistirebilir. Pürin metobolizmasi hipertansiyondan dolayi olan kan damarlaridaki daralmadan ve artan kalp atim hacminden etkilenebilir. Nitrik oksit sentazin (NOS) N sup omega Nitro-L-Arjinin Metil Ester (L-NAME) ile inhibisyonu siçanlarda hipertansiyona yol açar. Bu çalismanin amaci NOS inhibisyonu sonrasi siçanlarda renal doku adenozin deaminaz (AD) ve ksantin oksidaz (XO) aktivitelerini arastirmakti. Siçanlar üç gruba ayrildi; biri kontrol ve digerleri 15 gün süreyle içme sularinda 100 veya 500 mg/L L-NAME uygulanan çalisma gruplariydi. Yukarda açiklanan uygulamanin sonunda, anesteziye edilen siçanlarda karotid arter kanülasyonu yoluyla arteryel kan basinçlari ölçüldü. Renal dokuda AD ve XO aktiviteleri ölçüldü. Sistolik kan basinçlari L-NAME gruplarinda anlamli artis gösterdi. L-NAME gruplarindaki XO aktivitesi, kontrol grubuyla karsilastirildiginda anlamli olarak artmisti. AD aktiviteleri de L-NAME gruplarinda artmis olmasina karsin, bu artis anlamli bulunmadi. 100 mg ve 500 mg L-NAME gruplari arasinda XO ve AD aktiviteleri açisindan anlamli fark yoktu. Sonuçta, L-NAME ile indüklenen hipertansiyonun pürin nükleotidlerinde artisa neden oldugu kanisina vardik. Böylece, artmis XO ve AD enzim aktiviteleri sonucu birikmis pürin nükleotidleri renal dokudan uzaklastirilabilinir.
1-4

REFERENCES

References: 

1. Lacy F, Gough DA, Schmid-Schonbein GW. Role of xanthine oxidase in hydrogen peroxide production. Free Radic Biol Med 1998; 25: 720-727.
2. Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986; 548: 87-99.
3. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001; 21: 105-128.
4. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 1997; 811: 60-69.
5. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
6. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and
failure. Cardiovasc Res 1998; 39: 89-105.
7. Jover B, Mimran A. Nitric oxide inhibition and renal alterations. J Cardiovasc
Pharmacol 2001; 38 Suppl 2: S65-70.
8. Irmak MK, Koltuksuz U, Kutlu NO, Yagmurca M, Ozyurt H, Karaman A, Akyol O. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 2001; 29: 190-193.
9. Lowry O, Rosenbraugh N, Farr L, Rondall R. Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 183: 265-275.
10. Giusti G. Adenosine deaminase; in Bergmeyer MV (ed): Methods of Enzymatic Analysis. 2nd ed. New York, Academic Press 1974: 1092-1098.
11. Prajda N, Weber G. Malign transformation-linked imbalance: decreased XO
activity in hepatomas. FEBS Lett 1975; 59: 245-249.
12. Vural P. Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 2002; 317:
65-70.
13. Bergamaschi CT, Biancardi VC, Lopes OU, Campos RR. Effects of angiotensin blockade in the rostral ventrolateral medulla on maintenance of hypertension
induced by chronic L-NAME treatment. Brain Res 2002; 927: 195-199.
14. Yoneyama T, Ohkawa S, Watanabe T, Odamaki M, Kumagai H, Kimura M, Hishida A. The contribution of nitric oxide to renal vascular wall thickening in
rats with L-NAME-induced hypertension. Virchows Arch 1998; 433: 549-57.
15. Laakso J, Vaskonen T, Mervaala E, Vapaatalo H, Lapatto R. Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously
hypertensive rats. Life Sci 1999; 65: 2679-2685.
16. Jackson EK, Ohnishi A. Development and application of a simple microassay for adenosine in rat plasma. Hypertension 1987; 10: 189-197.
17. Kuan CJ, Wells JN, Jackson EK. Endogenous adenosine restrains renin release in conscious rats. Circ Res 1990; 66: 637-646.
18. Tofovic SP, Kusaka H, Li P, Jackson EK. Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats. Clin Exp
Hypertens 1998; 20: 329-344.
19. Higuchi Y, Ono K, Sekita S, Onodera H, Mitsumori K, Nara Y, Satake M.
Preventive effects of Shichimotsu-koka-to on renal lesions in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull 1998; 21: 914-918.

Thank you for copying data from http://www.arastirmax.com